Regional clozapine, ECT and lithium usage inversely associated with excess suicide rates in male adolescents Visa övriga samt affilieringar
2023 (Engelska) Ingår i: Nature Communications, E-ISSN 2041-1723, Vol. 14, nr 1, artikel-id 1281Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Advanced psychiatric treatments remain uncertain in preventing suicide among adolescents. Across the 21 Swedish regions, using nationwide registers between 2016-2020, we found negative correlation between adolescent excess suicide mortality (AESM) and regional frequencies of clozapine, ECT, and lithium (CEL) usage among adolescents (β = -0.613, p = 0.0003, 95% CI: -0.338, -0.889) and males (β = -0.404, p = 0.009, 95% CI: -0.130, -0.678). No correlation was found among females (p = 0.197). Highest CEL usage among male adolescents was seen in regions with lowest quartile (Q1) AESM (W = 74, p = 0.012). Regional CEL treatment frequency in 15-19-year-olds was related to lower AESM in males, reflecting potential treatment efficacy, treatment compliance or better-quality mental health care. Suicide prevention may benefit from early recognition and CEL treatment for severe mental illness in male adolescents. The results indicate association but further research, using independent samples and both prospective and observational methodologies, is needed to confirm causality.
Ort, förlag, år, upplaga, sidor Nature Publishing Group, 2023. Vol. 14, nr 1, artikel-id 1281
Nationell ämneskategori
Psykiatri
Identifikatorer URN: urn:nbn:se:umu:diva-206021 DOI: 10.1038/s41467-023-36973-4 ISI: 001035072200010 PubMedID: 36918566 Scopus ID: 2-s2.0-85150306127 OAI: oai:DiVA.org:umu-206021 DiVA, id: diva2:1746349
Forskningsfinansiär Vetenskapsrådet, 2020-01183 2023-03-282023-03-282025-04-24 Bibliografiskt granskad